Global L-Arabinose Market - 2020-2027
L-Arabinose is an isomer that arises naturally and is an integral part of polysaccharides in plants. Important bacterial numbers consist of an inducible operon of arabinose that codes for a set of transporters and enzymes. This helps L-arabinose to be used in microbial cultures as a sole source of carbon. It is present in nature as a component of biopolymers, such as hemicellulose and pectin. The biomolecular study is ongoing on the L-arabinose operon, also known as the araBAD operon. To recognize, separate, and classify pentose sugar isomerase, L-Arabinose is substantially used as a substrate. In the bio-production of L-ribose, L-Arabinose is also used. L-Arabinose is primarily used in food & beverage and pharmaceutical applications. In-plant cell walls, like corn, wheat, rye, rice, sugar beets, and plant gums, L-Arabinose is a naturally occurring pentose. It is commonly spread as a part of complex nonstarch polysaccharides. In vitro experiments with porcine intestinal mucosa demonstrated an inhibitory effect of L-arabinose on intestinal sucrase activity.
The global L-Arabinose market size was worth US$ XX billion in 2019 and further predicted to reach US$ XX billion by 2027, at a CAGR of XX% during the forecast period (2020-2027).
The major factors propelling the L-Arabinose market's growth are the escalated use of L-Arabinose as a substitute for Sugar in food and beverages and its added health benefits, which makes its utilization higher in pharmaceutical indiustry. The compound when introduced in diet offers benefits such as reduction in chanses of heart disease, prevention of type-2 Diabetes, lowering of blood cholesterol level and more. thus, L-arabinose's increasing demand from the Pharmaceutical sector drives the market growth during the forecast period. About 463 million people (aged 20-79 years) lived with Diabetes in 2019, according to the International Diabetes Federation, and the figure is projected to grow to 700 million by 2045. During the forecast era, increasing demand for L-arabinose from the pharmaceutical industry is projected to drive L-arabinose's global market. Moreover, addition of L-arabinose in diet is beneficial to prevent obesity. Increasing demand from the food & beverages industry, led by benefits of L-arabinose, is expected to have a positive impact on the global L-arabinose market in the near future.
One of the main causes affecting obesity is known to be Sugar. L-arabinose is a kind of natural maize cob sweetener that can be used as a food and beverage sugar substitute. People's eating patterns are unpredictable and unhealthy due to the growing intake of fast food and food with chemically added additives. This has resulted in increasing obesity cases across the globe. In 2018, 40 million children aged five years or younger worldwide were overweight or obese, according to the World Health Organisation (WHO). To curb the sugar intake and tackle obesity, the health consious population is shifting towards natural ingredients and subsitituing Sugar, leading to a boost in market growth.
When used as a part of diet, L-arabinose offers benefits such as reducing chances of development of heart diseases, lowering the blood cholesterol level, managing body weight and composition and preventing Type 2 diabetes. According to the International Diabetes Federation, approximately 463 million adults (aged 20-79 years) were living with Diabetes in 2019 and the number is expected to rise to 700 million by 2045. Rising demand for L-arabinose from the pharmaceutical sector is expected to drive the global L-arabinose market during the forecast period.
Lack of awareness concerning the health advantages of L-Arabinose among individuals is a key factor expected to curtail growth of the global market over the forecast period. L-Arabinose is a non-caloric sugar that can regulate the metabolism of glucose and lipids and inhibit obesity. The effect of L-arabinose on metabolic syndrome, a combination of medical disorders that raise the risk of Diabetes and cardiovascular disease, has been defined in a few studies.
COVID-19 Impact Analysis
The outbreak of COVID-19 has negatively impacted the growth of the L-Arabinose market globally. The disruption in the supply chain has majorly impacted the growth of the market amidst the pandemic. Therefore, the COVID-19 pandemic has hampered the market value of the L-Arabinose market in 2020.
Food Grade segment is projected to be the dominated segment in the market during the forecast period.
Food Grade dominated the global market in 2019, whereas the Pharma Grade is expected to present a considerable growth in the near future. The increasing use of L-Arabinose as a substitute for Sugar has made it a key ingredient in food and beverage processing. The increasing consumption of Food and beverages specially fast food drives the demand for L-Arabinose during the forecast period.
L-Arabinose is segmented on the basis of Application, which includes Food and Beverages, Pharmaceuticals, Others.
Food and Beverages is expected to dominate the L-Arabinose market.
Food and Beverages held the dominant position in the global market during the forecast period. The increasing utilization of L-Arabinose in Food and Beverage Industry as a sugar substitute coupled with the boost in the food and beverage processing sector across the globe supports the segment growth during the forecast period. Moreover, Pharmaceutical is expected to project a considerable CAGR during the forecast period. The added benefits of L-Arabinose, such as management of Cholesterol levels, prevention of diabetes and heart diseases propels lucrative market growth opportunities during the forecast period. In metabolic diseases such as Diabetes and reduced tolerance to glucose, glycaemic regulation is important. The hydrolysis of sucrose into glucose and fructose is blocked by L-arabinose. When sucrose was replaced by L-arabinose in beverages, glucose and insulin responses were decreased. Sucrose substitution in cereal foods did not affect glucose responses, although the insulin peak was decreased. In a cocktail, L-arabinose without sucrose did not impact glucose responses. Therefore, it is possibly a successful idea to substitute sucrose with L-arabinose to lower glycaemic and insulin responses.
Based on geography, the study analyzes the L-Arabinose market in the global market, including North America, Europe, Asia-Pacific, South America, and the Middle East & Africa.
Asia-Pacific held a dominant position in the global L-Arabinose market in 2019. In Asia-pacific, the boost in the Food and beverage sector has stirred the demand for L-Arabinose along with the changing lifestyles and shift towards fast food culture. Moreover, North America is expected to represent significant growth in terms of value during the forecast period. The increasing use in the pharmaceutical sector is expected to propel the market growth across the region. The L-Arabinose market for Asia Pacific is expected to observe rapid growth over the forecast period, backed by the increasing prevalence of major conditions such as heart diseases, obesity, Diabetes and more.
The L-Arabinose market is highly competitive, owing to the presence of big food brands. The key L-Arabinose players which are contributing to the growth of the global market include Danisco, Healtang, Nuara Biotech, Thomson Biotech, Xieli Bio-technology, MAK Wood, Futaste, Huakang Pharmaceutical, Lujian Biological, Longlive Bio-technology, among others. The major players are adopting new Type launch and expansion strategies for global growth in the L-Arabinose market.
Natural origin Rare Sugar Syrups are manufactured from sustainable wood-based or other biomass hydrolysates by aqueous chromatographic solvent free separation. The L - Arabinose Syrup offered is natural and non-GMO with applications as flavor and food ingredient. A considerable number of the employees are engaged in research and development of new products for the international food industry. Today, the Group holds more than 9,300 active patents and patent applications. Their work led to the understanding of the mechanism of CRISPR, the bacterial antiviral defense. CRISPR is a prokaryotic immune system that is both adaptive and inheritable.
Type Portfolio: The Company's portfolio comprises D-manose, D-Xylose Syrup LR, and among others
The global L-Arabinose market report would provide access to an approx.. 51 market data table, 45 figures and 221 pages.